Kayla Cristales

The Federal Trade Commission (“FTC”) announced a major crackdown on deceptive advertising for cannabidiol (“CBD”) products recently, taking aim at six sellers for mak...

Partners Michelle Jacobs and Suzie Trigg and Associates Jennifer Kreick and Kayla Cristales authored an article in Bloomberg Law examining the scope of PREP Act immunity for COVID-19 liabilit...

While the U.S. Department of Justice (DOJ) has identified and pursued a variety of fraud schemes and activities related to COVID-19 (such as sales of fake testing kits and PPE, price gouging, and frau...

Health Law Vitals - edition focused on Healthcare, Life Sciences, FDA and COVID-19. Browse a number of featured stories and quick reports on breaking news in this area.

After much anticipation, the FDA has begun, once again, to address its policies on cannabidiol (CBD) via:

1. FDA’s issuance of a second report to Congress regarding data collect...

A Haynes and Boone, LLP deal team represented Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) in a $25 million public offering of its common stock.

As healthcare providers respond to increased demands on supplies and resources due to the COVID-19 pandemic, regulators have issued certain flexibilities and guidance in responding to the public healt...

Today, the federal government enacted the Paycheck Protection Program and Health Care Enhancement Act (the “PPP/HCE Act”) to provide additional funding for loan and grant pro...

The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), a historic $2 trillion relief package signed into law on March 27, 2020, seeks to address the econom...

We recently discussed how the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) allocates $100 billion to the Public Health and Social Service Emergency Fu...